← Leaderboards
Richard Jove
University Of South Florida
$4,877,535
Attributed
$5,167,088
Total exposure
7
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $569.9K · FY2005–12$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$9,876,869 · 8
By mechanism
P01$5,210,775 · 3
R01$3,894,814 · 3
P30$771,280 · 2
Top collaborators
- Hua E Yu2 shared
Most similar at University Of South Florida
Same institution · by research overlap
- Timothy J Yeatman$17,520,103
- Said M Sebti$16,720,811
- William S. Dalton$20,173,582
- Warren Jackson Pledger$8,054,101
- Jianfeng Cai$10,262,045
Others in their field
Top investigators on “Molecular Oncology”
- Gregory H Reaman · National Childhood Cancer Foundation$243,743,268
- David Heimbrook · Leidos Biomedical Research, Inc.$218,489,003
- Peter C Adamson · National Childhood Cancer Foundation$151,727,370
- Richard L Schilsky · University Of Chicago$115,233,315
- Monica M Bertagnolli · Strang Cancer Prevention Center$101,803,003
- Walter John Curran · Thomas Jefferson University$74,079,477
Research focus
Molecular OncologyBiomedical FacilityNeoplasm /Cancer GeneticsTranscription FactorAntineoplasticsBiological Signal TransductionNeoplastic ProcessNeoplastic CellNeoplasm /Cancer ChemotherapyOncoproteinsDrug ResistanceMultiple MyelomaMalignant NeoplasmsCancer TherapyInsightGenesBreast NeoplasmsGrowthAffectAthymic MouseCell SurvivalLearningHuman Therapy EvaluationNeoplastic Transformation
Grant awards (35)
Role of Stat3 in Tumor Immune Evasion and Immune Suppression$289,553
R01 · FY2012 · CA
Role of Stat3 in Tumor Immune Evasion and Immune Suppression$289,553
R01 · FY2011 · CA
Inhibitors in Src Signaling for Antitumor Therapy$280,320
R01 · FY2011 · CA · contact PI
Inhibitors in Src Signaling for Antitumor Therapy$288,990
R01 · FY2010 · CA · contact PI
Inhibitors in Src Signaling for Antitumor Therapy$288,990
R01 · FY2009 · CA · contact PI
Inhibitors in Src Signaling for Antitumor Therapy$288,990
R01 · FY2008 · CA · contact PI
Inhibitors in Src Signaling for Antitumor Therapy$288,990
R01 · FY2007 · CA · contact PI
Molecular Signatures of STAT Regulated Genes in Cancer$349,036
R01 · FY2006 · CA · contact PI
Molecular Signatures of STAT Regulated Genes in Cancer$357,435
R01 · FY2005 · CA
MOLECULAR ONCOLOGY PROGRAM PROJECT$1,202,854
P01 · FY2004 · CA
Molecular Signatures of STAT Regulated Genes in Cancer$298,215
R01 · FY2004 · CA
MOLECULAR ONCOLOGY PROGRAM PROJECT$1,215,386
P01 · FY2003 · CA
Molecular Signatures of STAT Regulated Genes in Cancer$298,215
R01 · FY2003 · CA
MOLECULAR ONCOLOGY PROGRAM PROJECT$1,163,442
P01 · FY2002 · CA
Molecular Signatures of STAT Regulated Genes in Cancer$298,215
R01 · FY2002 · CA
DISRUPTION OF STAT SIGNALING PATHWAYS$197,196
P01 · FY2002 · CA
CORE--MOLECULAR ONCOLOGY PROGRAM$0
P30 · FY2002 · CA
STAT SIGNALING IN TUMOR PROGRESSION$0
P01 · FY2002 · CA
CORE--MOLECULAR ONCOLOGY PROGRAM$0
P30 · FY2002 · CA
CORE--MOLECULAR BIOLOGY$0
P30 · FY2002 · CA
CORE--MOLECULAR BIOLOGY$0
P30 · FY2002 · CA
MOLECULAR ONCOLOGY PROGRAM PROJECT$1,128,099
P01 · FY2001 · CA
CORE--MOLECULAR BIOLOGY$305,280
P30 · FY2001 · CA
CORE--MOLECULAR ONCOLOGY PROGRAM$305,280
P30 · FY2001 · CA
DISRUPTION OF STAT SIGNALING PATHWAYS$197,196
P01 · FY2001 · CA
CORE--MOLECULAR ONCOLOGY PROGRAM$0
P30 · FY2001 · CA
CORE--MOLECULAR BIOLOGY$0
P30 · FY2001 · CA
STAT SIGNALING IN TUMOR PROGRESSION$0
P01 · FY2001 · CA
SIGNAL TRANSDUCTION IN SRC ONCOGENESIS$278,312
R01 · FY2000 · CA
DISRUPTION OF STAT SIGNALING PATHWAYS$106,602
P01 · FY2000 · CA
CORE--MOLECULAR BIOLOGY$80,360
P30 · FY2000 · CA
CORE--MOLECULAR ONCOLOGY PROGRAM$80,360
P30 · FY2000 · CA
CORE--MOLECULAR BIOLOGY$0
P30 · FY2000 · CA
CORE--MOLECULAR ONCOLOGY PROGRAM$0
P30 · FY2000 · CA
STAT SIGNALING IN TUMOR PROGRESSION$0
P01 · FY2000 · CA